Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] - N0000193800

Pharmacologic Code	N0000193800
Pharmacologic Name	Cytomegalovirus DNA Terminase Complex Inhibitor
Pharmacologic Uses	CMV DNA terminase complex inhibitor
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 6 products whose active ingredient are classified under the same pharmacologic class Cytomegalovirus DNA Terminase Complex Inhibitor [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0006-3075	Prevymis	Non-Proprietary Name: Letermovir	Tablet, Film Coated	Oral	Merck Sharp & Dohme Llc	ACTIVE
	0006-3076	Prevymis	Non-Proprietary Name: Letermovir	Tablet, Film Coated	Oral	Merck Sharp & Dohme Llc	ACTIVE
	0006-5003	Prevymis	Non-Proprietary Name: Letermovir	Injection, Solution	Intravenous	Merck Sharp & Dohme Llc	ACTIVE
	0006-5004	Prevymis	Non-Proprietary Name: Letermovir	Injection, Solution	Intravenous	Merck Sharp & Dohme Llc	ACTIVE
	0006-5085	Prevymis	Non-Proprietary Name: Letermovir	Pellet	Oral	Merck Sharp & Dohme Llc	ACTIVE
	0006-5086	Prevymis	Non-Proprietary Name: Letermovir	Pellet	Oral	Merck Sharp & Dohme Llc	ACTIVE